Associate Director, Strategic Pricing, International Market Access & Pricing

The Associate Director, Strategic Pricing, iMAP will be responsible for calculating and articulating the financial impact of complex INTL pricing topics across the Therapeutics business. This includes high-priority areas such as the Most Favored Nations and International Reference Pricing Impact. The role demands agility in responding to evolving market dynamics and healthcare policy changes.

The global healthcare landscape is experiencing profound transformation due to regulatory shifts, not only from US entities such as CMS, but also from international governing bodies and government initiatives targeting pharmaceutical cost optimization across markets. As a result, pharmaceutical companies are revising their business practices and financial strategies to align with evolving international pricing policies and reimbursement structures. These changes carry widespread implications, impacting market access, pricing, and profitability on a global scale.

In this context, this position is essential for clearly articulating the financial impact of complex international pricing issues to senior management and the C‑Suite, enabling informed decision‑making and strategic planning in a highly dynamic international environment.

This position reports to the Head of International Pricing.

• Lead pricing analytics and presentations associated with the impact of global pricing reforms—including MFN‑based policies—across the international therapeutics portfolio. This includes a diverse set of in‑market and pipeline products with varying reimbursement structures and market access challenges across multiple geographies.
• Build and maintain pricing models to simulate the impact of International Reference Pricing (IRP) and Most Favored Nations (MFN) clauses on global revenue.
• Lead MFN discussions with senior management on an ad‑hoc basis, as well as during key planning cycles.
• Optimize the timing and order of product launches across international markets to minimize “price erosion” caused by cross‑border reference benchmarking.
• Develop “What‑If” scenario planning for entry into new therapeutic areas, forecasting long‑term price ceilings based on International Price Referencing competitor benchmarks.
• Ensure the accuracy of the global pricing database to prevent “cascading” pricing errors that could trigger involuntary price cuts in linked markets.
• Pricing lead in strategic discussions around MFN mitigation / revenue maximization with International and Global Pricing Council.
• Partner with Legal, Government Affairs, Market Access, Finance and other functions in INTL to determine impact of changes in US & INTL rules and regulations.
• Support Strategic Pricing Directors on an ad‑hoc basis as MFN Pricing subject matter expert.

• Lead the assessment and quantification of financial impact resulting from evolving healthcare policies, including International Reference Pricing, US Legislative changes and including Prescription Drug Affordability Board requests.
• Anticipate and analyze implications of healthcare policy shifts from governing bodies (e.g., CMS, G‑BA, MHML, CADTH, HAS) and new government initiatives (including Executive Orders), on INTL pricing strategies and business practices.
• Develop and implement strategic recommendations to optimize pricing/sales impact in response to dynamic policy environments.
• Build and maintain strong partnerships with cross‑functional teams, including Market Access, BESD, Brand teams, US Pricing and Brand teams, to ensure alignment and effective execution of pricing strategies.
• Synthesize complex data and insights into clear, actionable reports for Business Evolution and Strategy Development CoE.
• Present findings and strategic recommendations to senior management, including C‑Suite members, supporting evidence‑based decision‑making and long‑term business planning.
• Drive continuous improvement by leveraging data analytics and scenario planning to inform both short‑term and long‑term strategy development including future‑proof alternative solutions (data strategy & dynamic capabilities).
• Monitor global trends and best practices in…